Main Uses of Prometrium

Prometrium is a brand-name medication containing micronized progesterone, which is bioidentical to the hormone naturally produced by the human body. It is primarily prescribed to manage conditions associated with progesterone deficiency or hormonal imbalances in women.

Prevention of Endometrial Hyperplasia

One of the primary uses of Prometrium is for women who are undergoing estrogen replacement therapy during menopause. When estrogen is administered alone to a woman who still has a uterus, it can cause the lining of the uterus (the endometrium) to thicken excessively. This overgrowth, known as endometrial hyperplasia, can increase the risk of developing uterine cancer. Prometrium helps to counteract this effect by thinning the uterine lining, thereby maintaining a healthy hormonal balance.

Treatment of Secondary Amenorrhea

Prometrium is also indicated for the treatment of secondary amenorrhea, a condition characterized by the sudden cessation of menstrual periods in women who previously had a regular cycle. This often occurs due to a lack of sufficient progesterone production. By providing the necessary hormone, Prometrium can help trigger a withdrawal bleed and assist in restoring a regular menstrual cycle.

Benefits of Micronized Progesterone

Bioidentical Composition

Because Prometrium is composed of micronized progesterone, it is chemically identical to the progesterone produced by the ovaries. This bioidentical nature allows the body to metabolize the hormone in a way that mimics natural physiological processes.

Supporting Hormonal Balance

Beyond its primary indications, maintaining adequate progesterone levels can contribute to overall hormonal stability during the menopausal transition. By balancing the effects of estrogen, it helps manage the physiological changes associated with shifting hormone levels, supporting the maintenance of uterine health.

Regulatory References

1. NIH MedlinePlus overview of Progesterone

Who Can and Cannot Use Prometrium?

Prometrium (micronized progesterone capsules) is officially designated for adult women for specific regulated uses, such as managing secondary amenorrhea or as an adjunct to estrogen therapy in postmenopausal women with an intact uterus.

Absolute contraindications prohibit the use of this medicine in specific populations. Individuals must not use Prometrium if they have a known allergy to progesterone, the capsule ingredients, or peanuts (as the capsule contains peanut oil). Use is also strictly prohibited in women with severe liver disease, a known or suspected pregnancy, a history of breast cancer, or a past or active history of venous or arterial thromboembolic disease (e.g., DVT, stroke, or pulmonary embolism). Undiagnosed abnormal genital bleeding is also an absolute contraindication.

Regarding age, safety and efficacy have not been established in the pediatric population, and clinical data is insufficient for patients over 65. Use during breastfeeding is not recommended. Patients with mild to moderate hepatic or renal dysfunction require careful monitoring and conditional use as dictated by regulatory guidelines.

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Prometrium (micronized progesterone capsules) based on its metabolism and excipient content.

Interaction Restrictions

Classification	Constraint
Formal Contraindication	Use is prohibited in patients with a known allergy to peanuts, as the capsule contains peanut oil.
Population Restriction	Use is prohibited in patients with known severe liver disease or dysfunction, due to the critical role of the liver in progesterone metabolism.

Pharmacokinetic and Pharmacodynamic Interactions

The most prominent interactions involve the CYP3A4 enzyme system, which metabolizes progesterone. Substances classified as CYP3A4 inhibitors (e.g., Ketoconazole) may inhibit progesterone breakdown, leading to an increase in its plasma concentration. Conversely, CYP3A4 inducers (e.g., Rifampicin, Carbamazepine, Phenytoin) are documented to accelerate its metabolism, potentially resulting in a decrease in plasma concentration.

Prometrium is also documented to inhibit the P-glycoprotein efflux transporter, which may increase the exposure of co-administered P-gp substrate medicines. Furthermore, the co-administration of food significantly increases the bioavailability (AUC and Cmax) of the oral capsule. Other documented interactions include potential alteration of anti-diabetic medication effects and increased plasma levels of Ciclosporin.

How Prometrium Works

Prometrium (micronized progesterone) works by providing the natural hormone progesterone to the body, engaging specific molecular targets to regulate processes within the reproductive and central nervous systems. Its pharmacodynamic effects are achieved through two main mechanistic domains.

---

Genomic Modulation via Nuclear Receptors

Prometrium primarily acts as an agonist by binding to nuclear progesterone receptors (PR), which function as ligand-activated transcription factors. This binding initiates a slow, genomic cascade where the receptor-hormone complex translocates to the cell nucleus and modifies the transcription of specific target genes. This pathway is crucial for inducing the secretory transformation of the endometrium and modifies transcription to limit estrogen-driven cell proliferation, contributing to the physiological state of the secretory endometrium.

---

Rapid Signaling through Non-Genomic Pathways

In addition to genomic effects, the drug engages in faster non-genomic signaling by interacting with membrane-associated progesterone receptors and other signaling molecules, such as ion channels and cytoplasmic second messengers (e.g., ERK and cAMP). These rapid molecular steps lead to swift physiological adjustments, including the modulation of smooth muscle contractility (e.g., in the uterus) and neuroactive effects in the central nervous system, influencing cellular excitability and signaling activity in target tissues.

How Prometrium is Used: Administration and Dosing

The use of Prometrium (micronized progesterone capsules) is defined by prescribing information. The medication is for oral administration and must be swallowed whole with water, not crushed or chewed, as it is a soft gelatin capsule. Correct administration involves precise dosing, timing, and a cyclic schedule.

---

Dosing and Cyclic Schedules

Prometrium is administered according to the specific condition, utilizing a cyclic pattern rather than continuous daily use.

Condition	Daily Dose	Frequency	Duration/Cycle
MHT Endometrial Protection	200 mg	Once daily at bedtime	12 consecutive days per 28-day cycle
Secondary Amenorrhea	400 mg	Once daily at bedtime	10 consecutive days

---

Key Administration Instructions

The absorption of the micronized progesterone is sensitive to intake conditions, requiring specific adherence to administration instructions:

• Timing: The capsule is taken at bedtime once daily.
• Food Constraint: Dosing occurs without food, specifically two hours after the evening meal, to ensure proper pharmacological absorption.

Population-Specific Guidelines

Prescribing information places constraints on use in certain populations but provides no specific dose adjustments for others. Use in pediatric patients is not indicated, and the medication is generally not recommended for patients with known or suspected hepatic dysfunction or disease.

Research evidence / Overview of studies for Prometrium

Evidence for Use in Endometrial Protection

This section summarizes the research that examined the use of oral micronized progesterone alongside estrogen therapy in postmenopausal women who have an intact uterus. The medication was studied to examine its effect on the uterine lining (endometrium) to counterbalance changes often associated with estrogen-only therapy.

Research for this use is primarily based on Randomized Controlled Trials (RCTs), which are considered a rigorous study design, along with supporting systematic reviews. The study evidence is often referenced for the specific outcome it was designed to measure. It is important to note that these study results apply only to the populations studied under the specific conditions of the trials.

Evidence for Use in Secondary Amenorrhea

This section reviews the structure of the clinical trials and controlled studies that research examined whether the use of the medication was associated with the return of withdrawal bleeding in premenopausal women experiencing an absence of periods. The central outcome was observed in the studies was the incidence of withdrawal bleeding occurring within a short, defined window.

Long-Term Studies and Follow-Up

For the indication of endometrial protection, studies often tracked outcomes for intermediate periods, ranging from 12 to 36 months (up to three years). Data for certain groups remain insufficient regarding extended outcomes. Long-term outcomes are not fully established outside of the specific study observation periods.

Evidence Gaps and Areas of Uncertainty

For certain uses, the reliance on studies with modest sample sizes means that the full range of potential responses across a diverse population has limited data. Furthermore, comparative evidence is limited for certain regimens and outcomes. The evidence highlights what is known — and what is still uncertain — about patterns observed outside of the controlled conditions of the studies.

Common questions about Prometrium (FAQ)

---

Q: Do you have to take Prometrium with food?

A: According to the official product information, the capsule must be taken without food. This instruction is based on official data showing that taking the medication with a meal can significantly change how the body absorbs the progesterone. Official guidance specifies taking it two hours after your evening meal to ensure proper drug absorption.

---

Q: What is the purpose of Prometrium in combination hormone replacement therapy?

A: Regulatory documents state that when Prometrium is used as part of combination hormone replacement therapy (HRT) with estrogen, its primary purpose is to protect the uterine lining. Estrogen-only therapy can lead to an overgrowth of the uterine lining, which is why Prometrium is included to counterbalance this effect.

---

Q: Can Prometrium cause weight changes?

A: Official adverse reaction data notes that changes in weight, including both increases and decreases, have been reported in women using progestin medications generally. This information reflects documented observations from clinical data.

---

Q: Does Prometrium affect mood or cause emotional changes?

A: Adverse reaction data from official sources indicates that some patients have experienced mood-related effects. These documented effects include the occurrence of depression and emotional lability (instability of mood). Official product information notes that patients with a history of depression may require careful monitoring.

---

Q: Is there a link between Prometrium and changes in vision?

A: Official prescribing information notes that changes in vision, such as blurred vision, are documented as a potential warning sign of serious effects. Official documentation notes that changes in vision are warning signs of potentially serious effects.

---

Q: How quickly does Prometrium start working to address symptoms?

A: Official information does not provide a quantified timeline for when symptomatic relief might begin. However, common side effects often linked to the drug's activity, such as dizziness and drowsiness, are noted in the product summary as having an early, rapid onset.

---

Q: Can Prometrium be used during pregnancy?

A: According to the official prescribing information, Prometrium capsules are contraindicated and are not indicated for use during pregnancy. This classification indicates that the medication is not indicated for use when a patient is known or suspected to be pregnant.

---

Q: Does alcohol consumption affect how Prometrium works?

A: The drug can cause central nervous system side effects, most notably drowsiness and dizziness. Official documentation suggests that the use of alcohol may increase the likelihood or intensity of these effects.

---

Q: Is it okay to drive or operate machinery while taking Prometrium?

A: Official product information cautions against driving a motor vehicle or operating machinery. This is because side effects such as drowsiness and dizziness may occur after taking the capsule, which could impair alertness.

---

Q: Are there different strengths of Prometrium capsules available?

A: According to official dosage form listings, the oral capsules of Prometrium are currently available in two distinct marketed strengths: 100 mg and 200 mg.

---

Q: Does the time of day matter when taking Prometrium?

A: Yes, official administration instructions specify that the capsule must be taken at bedtime. The official timing is designed to coincide with bedtime due to the documented potential for side effects like drowsiness and dizziness.

---

Q: Can Prometrium cause stomach upset or nausea?

A: Yes, regulatory documents list gastrointestinal issues among the commonly reported adverse reactions. Specifically, nausea and abdominal pain are noted as side effects experienced by patients taking the medication.

---

Q: Does Prometrium interact with blood pressure medications?

A: Progestogens, the class of hormones Prometrium belongs to, are documented as possibly causing fluid retention, which could potentially worsen existing high blood pressure (hypertension) in certain patients. Official guidelines reflect a need for careful patient monitoring when the drug is used alongside blood pressure medications.

How to Store and Dispose of Prometrium?

This medication has specific official requirements for storage and handling to maintain its stability and effectiveness.

Official Storage Conditions

Storage Requirement	Specification
Temperature	Store below 30 C (86 F).
Handling Restriction	DO NOT REFRIGERATE. Protect from excessive heat and moisture.
Protection	Keep in the original packaging.
Child Safety	Keep out of the sight and reach of children.

Disposal Instructions

To safely dispose of the medicine, do not flush it down a toilet or put it in household garbage. If the medicine is expired, damaged, or no longer needed, it must be returned to a pharmacist or doctor for proper, professional disposal. Always ensure the product is secured away from children before disposal.